After liver injury, regeneration occurs through self-replication of hepatocytes. In severe liver injury, hepatocyte proliferation is impaired-a feature of human chronic liver disease 1,2 . It is unclear whether other liver cell types can regenerate hepatocytes [3][4][5] . Here we use two independent systems to impair hepatocyte proliferation during liver injury to evaluate the contribution of non-hepatocytes to parenchymal regeneration. First, loss of β1-integrin in hepatocytes with liver injury triggered a ductular reaction of cholangiocyte origin, with approximately 25% of hepatocytes being derived from a non-hepatocyte origin. Second, cholangiocytes were lineage traced with concurrent inhibition of hepatocyte proliferation by β1-integrin knockdown or p21 overexpression, resulting in the significant emergence of cholangiocyte-derived hepatocytes. We describe a model of combined liver injury and inhibition of hepatocyte proliferation that causes physiologically significant levels of regeneration of functional hepatocytes from biliary cells.
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After liver injury, regeneration occurs through self-replication of hepatocytes. In severe liver injury, hepatocyte proliferation is impaired-a feature of human chronic liver disease 1, 2 . It is unclear whether other liver cell types can regenerate hepatocytes [3] [4] [5] . Here we use two independent systems to impair hepatocyte proliferation during liver injury to evaluate the contribution of non-hepatocytes to parenchymal regeneration. First, loss of β1-integrin in hepatocytes with liver injury triggered a ductular reaction of cholangiocyte origin, with approximately 25% of hepatocytes being derived from a non-hepatocyte origin. Second, cholangiocytes were lineage traced with concurrent inhibition of hepatocyte proliferation by β1-integrin knockdown or p21 overexpression, resulting in the significant emergence of cholangiocyte-derived hepatocytes. We describe a model of combined liver injury and inhibition of hepatocyte proliferation that causes physiologically significant levels of regeneration of functional hepatocytes from biliary cells.
The identification of a liver stem or progenitor cell remains elusive 6 . Transplanted biliary progenitors can partly repopulate the liver's hepatocyte population 7, 8 but it is still unproved whether endogenous biliary cells can regenerate hepatocytes 3, 4 . Severe liver injury in human and animals impairs hepatocyte proliferation and causes ductular reactions to emerge 2, 9, 10 . Ductular reactions may arise from the biliary epithelium 11, 12 or through de-differentiation of hepatocytes 13 . Biliary cells in zebrafish models have been shown to regenerate the liver after massive hepatocytes loss 9, 25 ; however, this remains unproved in mammalian systems 3, 4, 14 . Lineage tracing of biliary ductular reactions into new hepatocytes, in the mouse, is dependent on both the severity and type of liver injury model, which have shown an inconsistent and limited contribution to hepatocyte regeneration 3, 4, 15, 16 . Mouse lineage-tracing experiments do not typically recapitulate human disease, as significant hepatocyte replication is seen alongside ductular reactions. We therefore sought to develop a model in which ductular reactions occur on the background of impaired hepatocellular regeneration and to evaluate the regenerative capacity of the ductular reactions.
We lineage traced hepatocytes using the highly efficient adenoassociated viral AAV8.TBG.Cre injected into a R26R LSL tdTomato mouse, thereby activating tdTomato (tdTom) expression in over 99.5% of hepatocytes (Extended Data Fig. 1a, b) . These mice had either wildtype (WT) Itgb1 (β 1-integrin WT ) or mutated Itgb1 (β 1-integrin fl/fl ) (Extended Data Fig. 1c-e) , previously shown to eliminate β 1-integrin expression 17 , thereby inhibiting hepatocyte growth factor signalling and impairing regeneration 18 . AAV8.TBG.Cre-mediated β 1-integrin ablation caused parenchymal damage with raised serum markers and cytoplasmic localization of high-mobility group box 1 protein (HMGB1), a damage-associated molecular pattern (DAMP) associated with liver necrosis and inflammation 19 Fig. 2g, h ).
We damaged β 1-integrin WT and β 1-integrin fl/fl livers with three independent regimes: DDC (3,5-diethoxycarbonyl-1,4-dihydrocollidine) diet, a model of cholestatic liver disease; methionine-and cholinedeficient (MCD) diet, a model of non-alcoholic steatohepatitis and thioacetamide (TAA); and a model of liver fibrosis 20 . We then studied the regenerative dynamics (Fig. 1a) . After DDC injury, all mice lost weight but β 1-integrin fl/fl mice had delayed weight recovery. β 1-Integrin fl/fl mice had prolonged hepatocellular Ki67 and p21 expression and elevated serum markers of liver injury (Extended Data Fig. 3a-d ), indicating that, after β 1-integrin loss, hepatocytes are unable to regenerate the injured liver efficiently. Hepatocyte Ki67 and p21 expression was rarely co-localized (Extended Data  Fig. 3e ). β 1-Integrin fl/fl livers had increased liver necrosis and recovered slowly from DDC injury (Extended Data Fig. 3f, g, asterisks) . There were increased ductular reactions after hepatocyte β 1-integrin loss, demonstrating that the DDC-induced injury remains unresolved in the absence of hepatocyte β 1-integrin (Fig. 1b) . Persistent ductular reactions were also found in β 1-integrin fl/fl livers that were injured with MCD and TAA (Fig. 1c) . After hepatocyte β 1-integrin loss, DDCinduced ductular reactions had atypical biliary cells, not confined to luminal structures (Fig. 1e , arrowheads, and Extended Data Fig. 4a , arrows). Ductular reactions in β 1-integrin fl/fl livers were surrounded by α SMA pos myofibroblasts that peaked in number by day 7 recovery; however, the degree of fibrosis increased throughout recovery (Fig. 1d , e and Extended Data Fig. 3h, i) .
To determine whether non-hepatocytes regenerated hepatocytes, we examined tdTom expression. After liver injury and recovery with DDC, MCD, and TAA, 20-30% of hepatocytes positive for CYP2D and HNF4α (mature hepatocyte markers) were tdTom neg ( Fig. 1f -h and Extended Data Fig. 4a, b) . Small, proliferative tdTom neg hepatocytes were identified from day 7 and increased significantly until day 14 (Extended Data Fig. 4c-e) . tdTom neg hepatocytes were normally found adjacent to SOX9 pos and CK19 pos ductal cells, and the number of tdTom neg hepatocytes decreased with distance from ductular reactions (Fig. 2a, b) . SOX9 pos /tdTom neg /HNF4α pos cells could be seen at the border between unlabelled parenchyma and ductular reactions (Fig. 2a) Fig. 4f, g ). The distribution of tdTom neg hepatocytes suggested a ductular origin; we therefore genetically labelled biliary cells and concurrently supressed Itgb1 expression specifically in hepatocytes with lipid-coated RNA interference (RNAi) nanoparticles 18, 21 (Fig. 2c) . The CK19 CreERT tdTomato LSL lineagetracing model specifically labels the biliary epithelium with a 40% recombination efficiency, and stringently excludes the hepatocyte lineage (Extended Data Fig. 5a, b) . After β 1-integrin RNAi treatment and DDC or MCD injury, cholangiocyte-derived periportal E-cadherin pos /tdTom pos /HNF4α hepatocytes were detected compared with RNAi controls (Fig. 2d) .
In humans, increased expression of p21 in hepatocytes is seen in chronic liver disease, suggesting that hepatocyte replicative potential becomes exhausted 1,2 . We sought to reproduce this in our mouse models of liver injury and regeneration by impairing hepatocyte proliferation to mobilize a traceable, biliary-derived hepatocyte regenerative response. To achieve this, we used a p21 coding region inserted into an AAV8 vector downstream of a thyroxine-binding globulin (TBG) promoter 22 to overexpress p21 in hepatocytes (Fig. 3a) . Liver Cdkn1a messenger RNA (mRNA) expression was six times higher in the AAV8-p21 injected group (Fig. 3b) . Hepatocyte p21 expression was observed after injection of the AAV8-p21 (Fig. 3c) . Liver histology remained normal (Extended Data Fig. 6a, b) . Proliferating nonparenchymal cells were seen close to the portal tracts (Fig. 3d) . Additionally, no significant changes in ductular reaction or collagen deposition were detected after p21 overexpression (Extended Data Fig. 6c, d ). To confirm that p21 overexpression was sufficient to inhibit hepatocyte proliferation, we induced acute liver injury after AAV8 injection (Fig. 3e) . Ki67 pos /HNF4α pos hepatocytes were only present in mice that received the AAV8-ctrl vector (Fig. 3f) , and p21 expression was increased in the AAV8-p21 group (Fig. 3f, g ). No significant changes in necrotic area were observed (Fig. 3h) , although serum transaminases were higher in the AAV8-p21 group (Fig. 3i) . ; before, during, and after injury (n = 5 DDC, n = 3 MCD, and n = 2 TAA; n = 3 for pre-injury αSMA analysis). PFV, per field of view. e, Confocal CK19/αSMA immunofluorescence; invasive biliary cells (arrowheads), ducts with lumens (arrows). f, h, Quantification of tdTom pos /HNF4α pos hepatocytes before, during, and after injury (n = 5 DDC, n = 3 MCD, and n = 2 TAA). g, Confocal tdTom immunofluorescence of CYP2D and HNF4α hepatocytes (n, number of mice per condition; experiments were performed once or twice). Scale bars, 100 μm. Data are mean ± s.e.m.; *P < 0.05; **P < 0.01; ***P < 0.001; two-way analysis of variance (ANOVA), Bonferroni post-tests. To induce ductular reactions on the background of impaired hepatocyte proliferation, we used the choline-deficient ethioninesupplemented (CDE) diet combined with AAV8-p21 or AAV8-ctrl (Extended Data Fig. 7a ). Hepatocyte proliferation was inhibited in mice in the AAV8-p21 group (Extended Data Fig. 7b, d ). Proliferating cells observed in the AAV8-p21 injected group were HNF4α neg (Extended Data Fig. 7c ). After CDE injury, there was a trend to increased ductular reactions in the AAV8-p21 group (Extended Data  Fig. 7e ). The AAV8-p21 group had persistent hepatocellular p21 expression 2 weeks after injury compared with control (Extended Data Fig. 7f ). mRNA analysis showed a 5-fold increase in p21 expression, and liver-damage-related genes such as Igfbp1 and Tgfb1 increased 20-fold and 2-fold respectively. In addition, a 4-fold increase in the ductular reaction gene Krt19 was found (Extended Data Fig. 7g ).
Together, these findings demonstrate that AAV8-p21 administration causes hepatocyte p21 accumulation and impaired hepatocyte proliferation after injury.
We used the CK19
CreERT tdTomato LSL lineage tracing model to test whether cholangiocytes gave rise to hepatocytes in various dietinduced liver injuries combined with p21 overexpression (Fig. 4a) . After the CDE, MCD, or DDC injury regimes ( Fig. 4a and Extended Data Fig. 8a , f), tdTom-expressing hepatocytes were observed in the AAV8-p21 group (Fig. 4b and Extended Data Fig. 8b, c, g, h) . tdTom pos cells contributed to 6.12 ± 0.3% of the liver 2 weeks after injury (Fig. 4b) .
Considering that the Krt19
CreERT tdTomato LSL system labels approximately 40% of all biliary cells, we corrected for this limitation in recombination efficiency, predicting that biliary cells differentiate into approximately 15.3% of hepatocytes in this model. Periodic acid-Schiff staining of serial liver sections showed the tdTom pos hepatocytes stored glycogen (Fig. 4c) . Other hepatocyte markers such as HNF4α , glutamine synthetase, and CYP2D were expressed by these cholangiocytederived tdTom pos hepatocytes ( Fig. 4d and Extended Data Figs 8d, i and 9a). These cholangiocyte-derived hepatocytes were present 10 weeks after injury (Extended Data Fig. 9b Fig. 10a-c) , and compared them against hepatocytes and cholangiocytes from injured WT mice. Gene expression between these cells was assessed with a drug metabolism quantitative PCR (qPCR) array and RNA sequencing (RNA-seq). Global transcriptional states of the biliary-derived hepatocytes from AAV8-p21-treated livers and tdTom neg hepatocytes from the β 1-integrin fl/fl model were highly similar to hepatocytes and distinct from ductal cells ( Fig. 4g and Extended Data Fig. 10d-f ). tdTom pos hepatocytes clustered closely with control WT hepatocytes (Fig. 4h) . Differences in the newly formed tdTom neg hepatocytes from the β 1-integrin fl/fl model may be explained by the continued presence of defective β 1-integrin fl/fl hepatocytes in the liver and their effect upon the tissue microenvironment (Extended Data Fig. 10e, f) .
In summary, we have studied impaired hepatocyte regeneration in two independent systems: hepatocyte β 1-integrin ablation and p21 overexpression. Both models triggered ductular reactions followed by clusters of cholangiocyte-derived hepatocytes. Multiple hepatocyte sub-populations have been suggested as regenerative under homeostasis 23, 24 or liver injury 14 . However, our findings show that while ductular reactions can be generated after injury, impaired hepatocyte regeneration is required for cholangiocytes to form hepatocytes. The mechanism of effect of the two models is different: β 1-integrin ablation causes hepatocyte necrosis, p21 expression, and inhibition of growth factor signalling 18 ; viral p21 overexpression directly inhibits hepatocyte proliferation. The common factor between the two models is impaired hepatocyte regeneration. This explains previous conflicting data from mouse, rat, and human disease, where the lack of differentiation seen in lineage-tracing models was probably due to ongoing effective hepatocyte-mediated regeneration. The full potential of cholangiocyte-derived hepatocyte regeneration may be higher as these are short-term injury models compared with human liver disease. These systems have now pos hepatocytes adjacent to the CK19 pos ductular reactions after DDC injury (n = 6 mice analysed, the experiment was performed twice). c, Experimental strategy to lineage trace biliary epithelial cells on a background of liver injury and hepatocyte Itgb1 silencing. d, Immunofluorescent confocal images and immunohistochemistry 14 days after DDC and MCD diet combined with RNAi-mediated β 1-integrin or luciferase mRNA suppression; arrowheads, bile ducts. Images are representative of n = 4 mice per condition, experiments were performed once. Scale bars, 100 μ m. Data are mean ± s.e.m. Cre tdTomato LSL livers after MCD recovery regime. Highmagnification images and quantification of tdTom-positive cells (insets) (n = 4 mice). c, Immunostaining of tdTom and periodic acid-Schiff staining on serial liver sections of AAV8-injected mice. d, Immunofluorescent double staining of HNF4α (green, top), glutamine synthetase (GS; green, middle), CYP2D (green, bottom), and tdTom (red). e, Double immunohistochemistry of tdTom (red), SOX9 (green, top), PanCK (green, bottom). f, Confocal images of serial liver sections of AAV8-injected mice; tdTom (red), HNF4α (green, left), PanCK (green, right), E-cadherin (E-cad; grey) (n = 4 mice). g, h, Pearson's correlation plot with hierarchical clustering and three-dimensional principal component analysis for total transcriptional landscapes (n = 3 mice). Scale bars, 100 μm. Data are representative of one or two independent experiments; experiments were repeated at least twice, except g and h were only performed once. Data are mean ± s.e.m. Mann-Whitney U-test, *P < 0.05. Ki67   AAV8 AAV8 AAV8 AAV8 AAV8 AAV8 AAV8 AAV8 AAV8 AAV8 AAV8 AAV8 AAV8 A  AAV8 A A AV  AAV8 AAV8 V8  AAV V8  AAV8 AAV8 AAV8 AAV8 AAV8 AAV AV8  AAV8 AAV8 AAV8 AAV AV V8  AAV8 AAV8 A AAV8 A AAV8 AAV AAV8 AAV8 AAV8 AAV8 AAV8 AAV8 AAV8 AAV8 AAV8 AAV8 AV8 AV8  AAV8 A AAV8 AAV V8  AV8  AAV8 V8 V8 8  A AV V  AV8  AAV8 A AAV8 AAV V V V  AAV8 AV8  AAV8 AV AV8 A 8 identified the cellular sources of regeneration in severely injured adult liver. This will facilitate studies into the signals controlling this regenerative pathway, aiding the development of liver regeneration therapies.
Online Content Methods, along with any additional Extended Data display items and Source Data, are available in the online version of the paper; references unique to these sections appear only in the online paper. Mice between 7 and 10 weeks of age had Cre-mediated recombination induced with AAV8.TBG.Pi.Cre.rBG (Penn vector core, CS0644). Control, null experiments used AAV8.TBG.Pi.null.rBG (Penn vector core, CS0255). Viruses were administered by tail vein injection at a concentration of 2.5 × 10 11 genome copies per millilitre. AAV8 viruses were diluted in sterile PBS. Mice were given a 2-week washout period before being placed on toxic injury diets.
Small interfering RNA (siRNA) formulated into lipidoid nanoparticles was used to silence Itgβ 1 mRNA in vivo. These siRNA nanoparticles have previously been shown to specifically suppress hepatocyte β 1 integrin expression 18, 21 . Doses (0.5 mg per kg (body weight)) were administered intravenously via the tail vein to each mouse every 5 days according to the schematic in Fig. 2c .
The Krt19
Cre TdTomato LSL mice was induced by three individual intraperitoneal injections of tamoxifen (20 mg ml −1 , Sigma UK) at a dose of 4 mg. K19Cre animals received 2 weeks of normal diet after the last tamoxifen injection before starting an injury diet regime.
To induce liver injury, mice were given 0.1% DDC mixed with Rat and Mouse No.1 Maintenance (RM1) diet (Special Diet Services), for 7-10 days; the MCD diet (MP Biomedicals) was given for 7-14 days; TAA (Sigma Aldrich) was administered in the drinking water at a concentration 300 mg l −1 for 21 days; the CDE diet began with a choline-sufficient CDE weaning diet for 1 week (MP Biomedicals, 960412) followed by 3 weeks of CDE diet (custom made by MP Biomedicals). After injury, dieted mice were given normal chow and drinking water. For the CCl 4 injury model, mice received one intraperitoneal injection of CCl 4 at a dose of 1 ml per kg (body weight) and were then euthanized 48 h later.
Partial hepatectomy (50%) was performed under isoflurane anaesthesia, and median laparotomy was performed followed by removal of the left lateral and upper left median lobe, as previously described 26 . Mice were euthanized 48 h after surgery. Mice were euthanized according to UK Home Office regulations. Blood was collected by cardiac puncture and centrifuged to collect serum. Organs were harvested and either directly frozen at − 80 °C or fixed in 10% formalin (in PBS) for 12 h. Formalin-fixed tissue was then stored in paraffin. Animals reaching experimental severity protocol boundaries were excluded from analysis, otherwise all animals were included. Animal studies were used throughout this work. Power calculations were not routinely performed; however, animal numbers were chosen to reflect the expected magnitude of response taking into account the variability observed in previous experiments. AAV8-p21 design and in vivo delivery. pGEM p21 was a gift from F. Mushinski (Addgene plasmid 8443). The p21 plasmid was packaged into the AAV8.TBG vector by Penn Vector Core. AAV8-ctrl plasmid (AAV8.TBG.PI.Null.bGH, catalogue number AV-8-PV0148) was obtained from Penn Vector Core. Viral particles (7.5 × 10 11 ) were reconstituted in 100 μ l injected intravenously through tail vein injection with BD Ultra-Fine Insulin Syringes. Histology, immunohistochemistry, and immunofluorescence. Formalin-fixed tissue embedded in paraffin. Sections (4 μ m) were blocked with protein block (Spring Bioscience) and stained overnight at 4 °C using the antibodies listed in Supplementary Table 1. Primary antibodies were detected using fluorescentconjugated secondary antibodies (Alexa Fluor 488/Alexa Fluor 555 and Alexa Fluor 657; Invitrogen). Sections were stained with DAPI (4′ ,6-diamidino-2-phenylindole) and mounted with Fluoromount-G (SouthernBiotech). For DAB-stained sections, tissue was blocked with Bloxall (Vector), Avidin/Biotin block (Invitrogen), and protein block. Primary antibodies were incubated overnight at 4 °C. Species-specific secondary biotinylated antibodies (Vector), R.T.U. Vectastain, ABC reagent (Vectar), and DAB chromogen (Dako) were used to detect the primary antibody. Haematoxylin counterstain was used alongside the DAB.
When two antibodies from the same species were used, Sox9/RFP/HNF4α immunofluorescent stain primary antibodies were applied sequentially. The first antibody to be applied, anti-RFP, was detected using a species-specific secondary antibody (Dako) conjugated to HRP and a Perkin Elmer TSA Plus Cyanine 3 signalling amplification kit (NEL744B001KT). This was followed by a second antigen retrieval to denature any antibodies in the tissue and prevent cross-reaction with the following antibody application.
Haematoxylin and eosin stains were automatically produced using a Shandon Varistain Automated Slide Stainer. PicroSirius Red stains used reagents from Sigma Aldrich: picric acid, catalogue number P6744-1GA; fast green, catalogue number F7258-25G; direct red, catalogue number 365548-25G. Staining was done according to the manufacturer's instructions. Microscopy and cell counting. For confocal microscopy, either a Leica SPE inverted microscope or a Zeiss LSM 780 confocal microscope were used and images were deconvoluted using Fiji ImageJ. Brightfield images were taken using a Nikon Eclipse e600 microscope and Retiga 2000R camera (Q-Imaging) and acquired with Image-Pro Premier software. PicroSirius Red analysis used an AxioScan Z.1 (Zeiss) to acquire tiled images at × 20 magnification. De-tiled images were then analysed using a standard colour threshold in Fiji Image J. Necrotic areas were quantified using haematoxylin and eosin histochemistry and the trainable WEKA segmentation tool in Fiji Image J.
Fluorescent tiled images were generated on a Perkin Elmer Operetta highcontent imaging system; subsequent image stitching was done on Fiji ImageJ using the pairwise stitching plugin 27 . DAPI, Alexa Fluor 488, and Alexa Fluor 555 were detected using excitation band-pass filters of 360-400, 460-490, 520-550 nm and emission band-pass filters of 410-480, 500-550, 560-630 nm, respectively. In cases where manual quantification was performed (including animal experiments), counts were performed on blinded slides and more than 20 consecutive non-overlapping fields at × 100 or × 200 magnification. Single-cell liver tissue analysis. Images were acquired in up to four fluorescent channels at × 10 magnification on a Perkin Elmer Operetta high-content imaging system and subsequently analysed using the Columbus software. An average of 25 images were taken per liver section. One field of view corresponded to 1.37 mm 2 . DAPI-stained nuclei were identified on the basis of pixel intensity using method 'M' with approximately 7,000 nuclei identified per field. Nuclear size and morphology were then determined. Illumination correction and background normalization were performed using the sliding parabola module. Depending on the experiment, nuclei were then assigned as positive or negative on the basis of the mean pixel intensity in the corresponding channel in either the nucleus (HNF4α , tdTom, Ki67, P21, and PCNA) or a 7 μ m thick region surrounding the nucleus (CK19 and α SMA). For each experiment, identical thresholds were used in all images for assigning nuclei to a specific population. Protein homogenates and western blots. Protein was isolated from whole liver. Small, 1-2 mm 2 pieces of liver were homogenized using a Tissue-Tearor (Biospec Products) and lysis buffer (150 mM NaCl, 20 mM Tris pH 7.5, 1 mM EGTA, 1 mM EDTA, 1% Triton X-100, 2× Protease Inhibitor Cocktail (Sigma Aldrich)). Samples were mixed at 4 °C for 30 min and then centrifuged for 10 min at 20,000g. The aqueous supernatant was removed and the protein concentration was determined using a Pierce BCA Protein Assay Kit (Thermo Scientific). Proteins were separated using SDS-polyacrylamide gel electrophoresis and transferred to nitrocellulose membranes; anti-β 1-integrin (Millipore, MAB1997) 1/1,000 and anti-β -actin (Cambridge Biosciences) 1/2,000 were used to detect proteins. Isolation of biliary ducts and hepatocytes, and FACS. Hepatocytes and biliary ducts were isolated using the classical perfusion protocol. Briefly, animals received an overdose of anaesthetic followed by laparotomy: the portal vein was cannulated and injected with Liver Perfusion Medium (Gibco) and Liver Digest Medium (Gibco). For duct isolation, ducts were digested and isolated as previously described 8 . For hepatocyte isolation, the liver was removed and mechanically disaggregated. The resulting disassociated cells were filtered through a 70 μ m filter (BD Biosciences). Hepatocytes were purified with a density gradient centrifugation 28 , which isolated cells with hepatocyte morphology and expression of CYP2D6 (a mature hepatocyte marker) at a purity greater than 99% (ref. 7). Briefly, cells were layered above various Percoll solutions: 1.06, 1.08, and 1.12 mg ml −1 Percoll (Sigma) in PBS. Cells were spun at 750g for 20 min. The hepatocyte layer, between the 1.08 and 1.12 mg ml −1 Percoll layers, was collected for FACS. Purified hepatocytes were sorted on a BD Biosciences Fusion Flow Cytometer. Sorted cells where lysed and the RNA was extracted. RNA isolation and qPCR with reverse transcription. Liver tissue was homogenized in TRIzol (Life Technologies). Homogenates were mixed with chloroform (1:5 ratio chloroform:TRIzol) and centrifuged at 4 °C, 1,200g, for 15 min. The aqueous supernatant was removed and mixed 1:1 with 70% ethanol. RNA was extracted using a Qiagen RNeasy Mini Kit according to the manufacturer's instructions. Reverse transcription and qPCR were performed using Qiagen QuantiTect and QuantiFast reagents on a LightCycler 480 II (Roche). Commercial primers from Qiagen's QuantiTect range were used: Cdkn1a (Qiagen QT00137053), Igfbp1 (Qiagen QT001114716), Tgfb1 (Qiagen QT00145250), krt19 (Qiagen QT00156667), β 1-integrin (Qiagen, QT00155855), and peptidylprolyl isomerase A letter reSeArCH (PPIA; Qiagen QT00247709). Gene expression was normalized to the housekeeping gene, PPIA. Samples were run in triplicate. The RT 2 Profiler PCR Array, Drug Metabolism: Phase I Enzymes was purchased from Qiagen (330231 PAMM-068Z), and complementary DNA (cDNA) was synthesized from extracted RNA using the RT 2 First Stand Kit (Qiagen; 330401) according to the manufacturer's instructions. The RT 2 Profiler PCR Array was run on a Roche LightCycler 480 II with RT 2 SYBR Green qPCR Mastermix (Qiagen; 330500), according to the manufacturer's instructions. Analysis were performed according to the manufacturer's templates and guidelines. Whole-genome RNA-seq. Samples were treated with DNase (Ambion), and sample integrity verified on an Agilent Bioanalyser with the RNA Nano chip. Illumina Tru-seq paired-end strand-specific sequencing (Illumina, USA) was performed on a NextSeq-550 sequencer (Edinburgh Clinical Research Facility, Western General Hospital, Edinburgh, UK). Total RNA (500 ng) underwent ribosomal RNA depletion before purification, fragmentation, random hexamer cDNA generation, and purification with AMPure XP beads (Beckman-Coulter, USA). Multiple indexing adapters were ligated to double-stranded cDNA with subsequent hybridization onto flow cells, and DNA fragment enrichment by 15-cycle PCR for sequencing. Completed libraries were quantified by qPCR using a KAPA Illumina Library Quantification Kit (Illumina, USA) before multiplexing in two equimolar pools and running on two flow cells on an Illumina NextSeq 550. The resulting FastQ files were mapped to the reference genome (mm9) using the Tophat alignment tool (version 2) on Illumina Basespace software and reads per kilobase per million (RPKM) scores calculated for each gene. Differential gene expression was done using DEseq with cutoffs of log 2 (fold change) > 2 and adjusted P < 0.05 within replicates applied. Global analysis of total RPKM data sets to assess overall transcriptional states was done by calculating and plotting Pearson's correlation scores visualized as a heatmap with Euclidian and Ward clustering applied. Principal component analysis plots were also performed with the use of Illumina Basespace software. Plots for Pearson's correlation scores with hierarchical clustering were also performed on all genes displaying significant gene expression changes relative to the control set. Visual examples of the transcriptional data were generated by calculating the average expression per group (control, β 1 integrein fl/fl , AAV8-p21, and biliary duct) and loading onto the Broad Institute's Integrative Genomics Browser (https://software.broadinstitute.org/software/igv/download). RPKM values for select gene sets (hepatocyte, biliary, Notch signalling, and Wnt signalling) were also clustered by Euclidian and Ward methods and expression patterns visualized by plotting them as a Z-score heatmap with row-normalized values. Data files can be accessed at the Gene Expression Omnibus under accession number GSE98034. Statistical analysis. Prism software (GraphPad Software) was used for all statistical analysis. Data are presented as mean ± s.e.m.; n refers to the number of biological replicates. Normal distribution of data was determined using a D' Agostino and Pearson omnibus normality test. For parametric data, data significance was analysed using a two-tailed unpaired Student's t-test. In cases where more than two groups were being compared, a one-way ANOVA was used. In cases where two groups were split between two independent variables, a two-way ANOVA was used. In instances where n was too small to determine normal distribution or the data were non-parametric, a two-tailed Mann-Whitney U-test was used. F-tests were used to compare variances between groups.
In cases where randomization was used (including animal studies), samples were randomized by a 'blinded' third party before being assessed by a separate 'blinded' assessor. Unblinding was performed immediately before final data analysis. Serum analysis. Serum analysis used commercial kits according to the manufacturer's instructions: alanine transaminase, albumin, bilirubin (Alpha Laboratories); aspartate aminotransferase, and alkaline phosphatase (Randox laboratories). All kits were adapted for use on a Cobas Fara centrifugal analyser (Roche). Reproducibility of experiments. Routinely, qPCR experiments were performed in technical triplicates of multiple biological replicates. For representative images, three or four liver lobes were examined histologically in at least three biological replicates; further details referring to the specific numbers of biological replicates for each experiment can be found in the figure legends. Data availability. Data generated during this study are available in the Gene Expression Omnibus under accession number GSE98034. All other data are available from the corresponding author upon reasonable request. 
